MktsMarkets

Rani Therapeutics Holdings, Inc.
NASDAQ: RANIKey statistics
RANI News
Stories mentioning RANI from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 1,708 | 1,461 | 0.00 | 0.00 | 172.00 | 1,028 | 0.00 | 0.00 |
| Cost of Goods Sold | ||||||||
| Gross Profit | ||||||||
| Operating Expenses | ||||||||
| Research & Development | 5,161 | 4,909 | 3,221 | 5,505 | 6,570 | 6,809 | 6,172 | 6,115 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 10,047 | 9,996 | 7,257 | 10,505 | 12,185 | 15,985 | 11,799 | 12,524 |
| Operating Income (Loss) | (8,339) | (8,535) | (7,257) | (10,505) | (12,013) | (14,957) | (11,799) | (12,524) |
| Interest Income | ||||||||
| Interest Expense | 88.00 | 346.00 | 725.00 | 877.00 | 943.00 | 1,126 | 1,337 | 1,276 |
| Other Expense | ||||||||
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (7,033) | (10,305) | (5,412) | (6,692) | (7,264) | (8,947) | (6,783) | (6,805) |
| Earnings Per Share (Basic) | (0.04) | (156.14) | (0.12) | (0.18) | (0.22) | (319.54) | (0.24) | (0.26) |
| Earnings Per Share (Diluted) | (0.04) | (156.14) | (0.12) | (0.18) | (0.22) | (319.54) | (0.24) | (0.26) |
| Weighted Average Shares Outstanding (Basic) | 179,996 | 66.00 | 46,444 | 36,542 | 33,440 | 28.00 | 28,836 | 26,324 |
| Weighted Average Shares Outstanding (Diluted) | 179,996 | 66.00 | 46,444 | 36,542 | 33,440 | 28.00 | 28,836 | 26,324 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About RANI
Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) is a stock listed on the Nasdaq Stock Market under the ticker symbol RANI. It last traded at $0.6100 (Oct 29, 2026, 4:00 PM ET), down 1.6% on the day. That gives Rani Therapeutics a market capitalisation of $84.4M.
Over the past 52 weeks RANI has traded between $0.5700 and $2.63.
Revenue for the quarter ended Mar 31, 2026 was $1.7M; a net loss of $7.0M. Revenue was up 893% from $172.0K in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $1.7M | -$7.0M | -411.8% |
| Dec 31, 2025 | $1.5M | -$10.3M | -705.3% |
| Sep 30, 2025 | $0 | -$5.4M | — |
| Jun 30, 2025 | $0 | -$6.7M | — |
From Rani Therapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…